Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C. [electronic resource]
Producer: 20110428Description: 452-8 p. digitalISSN:- 1572-0241
- Adult
- Antiviral Agents -- therapeutic use
- Drug Carriers
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Polyethylene Glycols -- administration & dosage
- Polymerase Chain Reaction
- RNA, Viral -- isolation & purification
- Recombinant Proteins
- Retrospective Studies
- Ribavirin -- therapeutic use
- Treatment Failure
- Treatment Outcome
- Viral Load -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.